Skip to main content

KalVista Pharmaceuticals, Inc. insider trading

KALV
$27.00Delayed · as of Jun 10, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Jun 10, 2026 to Jun 10, 2026. Price (+0.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flow

Key players

  • BLBenjamin L. PalleikoCHIEF EXECUTIVE OFFICER0.00%of company
  • CYChristopher YeaCHIEF DEVELOPMENT OFFICER0.00%of company
  • PKPaul K. AudhyaCHIEF MEDICAL OFFICER0.00%of company
  • NSNicole SweenyChief Commercial Officer0.00%of company
  • BPBrian PiekosChief Financial Officer0.00%of company
  • VMVHCP Management III, LLC10% OwnerNot reportedof company
  • VHVenrock Healthcare Capital Partners EG, L.P.10% OwnerNot reportedof company
  • VHVenrock Healthcare Capital Partners III, L.P.10% OwnerNot reportedof company
  • VMVHCP Management EG, LLC10% OwnerNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
KALVPaul K. AudhyaCHIEF MEDICAL OFFICEROpen market sell$60K-1.5%$26.78$60KMay 26, 2026May 27, 2026
KALVNicole SweenyChief Commercial OfficerOpen market sell$39.9K-2.5%$26.78$39.9KMay 26, 2026May 27, 2026
KALVChristopher YeaCHIEF DEVELOPMENT OFFICEROpen market sell$52.6K-0.9%$26.78$52.6KMay 26, 2026May 27, 2026
KALVPaul K. AudhyaCHIEF MEDICAL OFFICEROpen market sell$71.9K-1.8%$26.78$71.9KMay 22, 2026May 26, 2026
KALVNicole SweenyChief Commercial OfficerOpen market sell$49.8K-3.2%$26.78$49.8KMay 22, 2026May 26, 2026
KALVBrian PiekosChief Financial OfficerOpen market sell$39.9K-6.4%$26.78$39.9KMay 22, 2026May 26, 2026
KALVChristopher YeaCHIEF DEVELOPMENT OFFICEROpen market sell$63.1K-1.0%$26.78$63.1KMay 22, 2026May 26, 2026
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$293K-2.2%$26.78$293KMay 22, 2026May 26, 2026
KALVPaul K. AudhyaCHIEF MEDICAL OFFICEROpen market sell$27.6K-0.7%$26.76$27.6KMay 18, 2026May 19, 2026
KALVChristopher YeaCHIEF DEVELOPMENT OFFICEROpen market sell$29.7K-0.5%$26.76$29.7KMay 18, 2026May 19, 2026
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$30.2K-0.2%$26.76$30.2KMay 18, 2026May 19, 2026
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$88.7K-0.7%$26.71$88.7KMay 12, 2026May 13, 2026
KALVPaul K. AudhyaCHIEF MEDICAL OFFICEROpen market sell$54.3K-1.9%$20.22$54.3KApr 17, 2026Apr 20, 2026
KALVNicole SweenyChief Commercial OfficerOpen market sell$37.6K-3.5%$20.22$37.6KApr 17, 2026Apr 20, 2026
KALVBrian PiekosChief Financial OfficerOpen market sell$37.6K-9.3%$20.22$37.6KApr 17, 2026Apr 20, 2026
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$193K-2.0%$20.22$193KApr 17, 2026Apr 20, 2026
KALVVenrock Healthcare Capital Partners EG, L.P.10% OwnerOpen market sell$60.9K-0.1%$19.12$60.9KMar 26, 2026Mar 27, 2026
KALVVenrock Healthcare Capital Partners EG, L.P.10% OwnerOpen market sell$290K-0.3%$18.82$290KMar 26, 2026Mar 27, 2026
KALVVenrock Healthcare Capital Partners EG, L.P.10% OwnerOpen market sell$380K-0.4%$17.76$380KMar 26, 2026Mar 27, 2026
KALVVenrock Healthcare Capital Partners EG, L.P.10% OwnerOpen market sell$2.8K0.0%$17.53$2.8KMar 25, 2026Mar 27, 2026
KALVVenrock Healthcare Capital Partners EG, L.P.10% OwnerOpen market sell$2.96M-3.3%$16.95$2.96MMar 25, 2026Mar 27, 2026
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$108K-1.5%$16.08$108KMar 9, 2026Mar 10, 2026
KALVPaul K. AudhyaCHIEF MEDICAL OFFICEROpen market sell$83.4K-3.7%$15.57$83.4KFeb 23, 2026Feb 24, 2026
KALVNicole SweenyChief Commercial OfficerOpen market sell$61.9K-7.8%$15.57$61.9KFeb 23, 2026Feb 24, 2026
KALVBrian PiekosChief Financial OfficerOpen market sell$27.5K-11.4%$15.57$27.5KFeb 23, 2026Feb 24, 2026
KALVChristopher YeaCHIEF DEVELOPMENT OFFICEROpen market sell$67.7K-1.9%$15.57$67.7KFeb 23, 2026Feb 24, 2026
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$156K-2.2%$15.57$156KFeb 23, 2026Feb 24, 2026
KALVPaul K. AudhyaCHIEF MEDICAL OFFICEROpen market sell$17.4K-0.9%$15.00$17.4KFeb 18, 2026Feb 19, 2026
KALVChristopher YeaCHIEF DEVELOPMENT OFFICEROpen market sell$16.6K-0.5%$15.00$16.6KFeb 18, 2026Feb 19, 2026
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$15.6K-0.2%$15.00$15.6KFeb 18, 2026Feb 19, 2026
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$52.7K-0.8%$15.70$52.7KFeb 12, 2026Feb 13, 2026
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$120K-1.7%$16.51$120KDec 8, 2025Dec 9, 2025
KALVPaul K. AudhyaCHIEF MEDICAL OFFICEROpen market sell$71.2K-3.9%$13.45$71.2KNov 24, 2025Nov 26, 2025
KALVNicole SweenyChief Commercial OfficerOpen market sell$51.3K-8.8%$13.45$51.3KNov 24, 2025Dec 4, 2025
KALVBrian PiekosChief Financial OfficerOpen market sell$60.1K-29.8%$13.45$60.1KNov 24, 2025Nov 26, 2025
KALVChristopher YeaCHIEF DEVELOPMENT OFFICEROpen market sell$58.3K-1.9%$13.45$58.3KNov 24, 2025Nov 26, 2025
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$147K-2.6%$13.45$147KNov 24, 2025Nov 26, 2025
KALVPaul K. AudhyaCHIEF MEDICAL OFFICEROpen market sell$44.5K-2.4%$14.48$44.5KNov 18, 2025Nov 19, 2025
KALVChristopher YeaCHIEF DEVELOPMENT OFFICEROpen market sell$38.8K-2.0%$14.48$38.8KNov 18, 2025Nov 19, 2025
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$64.7K-1.1%$14.48$64.7KNov 18, 2025Nov 19, 2025
KALVBenjamin L. PalleikoCHIEF EXECUTIVE OFFICEROpen market sell$38.4K-0.8%$11.55$38.4KNov 12, 2025Nov 13, 2025
End of history · 41 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.